BCI Industry and Company Updates

Paradromics blog

Read our latest articles or sort by topic below.

Featured

Think Fast

October 3, 2025

Setting new standards and new records for brain-computer interfaces

Paradromics Connexus BCI sets new records with the SONIC benchmark, achieving 200+ bps and low latency, defining a new standard for BCIs.

AI is not the bottleneck in BCI

Rapid advances in AI make BCI hardware development even more important

October 15, 2025

AI is moving fast, but BCI hardware must advance in parallel to truly connect the two technologies and drive meaningful BCI progress.

Setting new standards and new records for brain-computer interfaces

October 3, 2025

Paradromics Connexus BCI sets new records with the SONIC benchmark, achieving 200+ bps and low latency, defining a new standard for BCIs.

Life in the slow lane

September 19, 2025

Explore the surprising bandwidth limitations of the human mind and body, and how BCI technology can restore and enhance our full experience.

Articles by topic

Neurotech articles

Neurotech

The speed of human thought, and its implications for brain-computer interfaces

September 19, 2025

Explore the surprising bandwidth limitations of the human mind and body, and how BCI technology can restore and enhance our full experience.

Neurotech

Electrocorticography (ECoG) surveys the landscape

September 11, 2025

Electrocorticography remains key for neurosurgery, but its ceiling in BCI neurotech shows why higher-resolution BCI interfaces drive next-gen neurotechnology.

Neurotech

BCI experiences

August 1, 2025

BCI users report that neuroprosthetics feel like a natural extension of the body, enabling new independence and expression.

Neurotech

Neurotech that lasts

May 14, 2024

Paradromics is advancing neurotech with durable brain interface technology designed to restore speech and computer control for people in need.

Neurotech

Neuroengineering the brain

October 18, 2022

Just as pumps aid hearts and dialysis aids kidneys, brains need data interfaces to restore lost function.

Neurotech

Healthcare innovation

July 7, 2022

BCI’s are a healthcare innovation, poised to transform care for neurological and mental health conditions.

Neurotech

Augmentative and alternative communication BCIs

May 10, 2022

Researchers have long recognized that brain-computer interfaces (BCIs) could offer a solution for those with augmentative and alternative communication needs.

Neurotech

BCI tech

October 24, 2022

BCI tech is revolutionizing healthcare, with brain implants poised to transform neurological and mental health treatment.

Neurotech

BCI news

April 10, 2022

Stay updated with the latest BCI news and neurotech insights from Paradromics, a top BCI maker delivering healthtech solutions for medical challenges.

Company update articles

Company Updates

Think Fast

October 3, 2025

Paradromics Connexus BCI sets new records with the SONIC benchmark, achieving 200+ bps and low latency, defining a new standard for BCIs.

Company Updates

Preclinical research and neural signal stability

June 5, 2025

Animal studies show over 3 years of stable recordings and sustained BCI decoding capabilities.

Regulatory Articles

Regulatory

Healthtech and the FDA

July 8, 2024

The FDA continues to work with healthtech innovators to meet the expanding size of the BCI market.

Regulatory

Neuroethics

July 8, 2024

The iBCI-CC addresses profound ethical questions on BCI privacy, autonomy, and misuse.

AI Articles

AI is not the bottleneck in BCI

October 15, 2025

AI is moving fast, but BCI hardware must advance in parallel to truly connect the two technologies and drive meaningful BCI progress.

AI and healthcare

May 23, 2024

At the intersection of AI and healthcare, brain interfaces are redefining what’s possible in treatment and care.

Neurotech Pub Podcast

Join Paradromics Founder and CEO Matt Angle in conversation with neuroscience experts. Check out some of the recent episodes.

Listen to podcast

Product About News Blog

Podcast BCI Community Careers Contact

Legal

Conflicts of Interest Policy